What We're Reading: Page
Industry reads hand-picked by our editors
Sep 11, 2024
-
AP News
Saxenda, a weight-loss drug, is effective for kids as young as 6, study shows
-
Fierce Biotech
Roche ramps up R&D with new high-rise labs
-
Bloomberg
GTCR Is in Advanced Talks to Buy German Drugmaker Stada
-
The New York Times
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementia
Sep 10, 2024
Sep 09, 2024
-
Financial Times
Pricy new cancer drugs offer patients hope but pile pressure on health budgets
-
Bloomberg
Roche Falls as Side Effects Data for Obesity Drug Raises Concern
-
NPR
Drugmakers say Ozempic, Wegovy and similar drugs are widely available. Patients disagree.
-
C&EN
Thinking on linkers for antibody-drug conjugates
Sep 06, 2024
Sep 05, 2024
Sep 04, 2024
-
The New Yorker
How A.I. Teaches Machines to Discover Drugs
-
Axios
Startup raises $191 million to edit pig organs for human transplant
-
The Wall Street Journal
‘She Didn’t Seem Right Yet’: The Deadly Threat to New Mothers
-
Fierce Biotech
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Sep 03, 2024
-
Bloomberg
Bayer Kidney Drug Helps Treat Common Form of Heart Failure
-
The Washington Post
Coronavirus vaccines are now pricey without insurance as CDC access program expires
-
Stat
A cancer survivor’s journey from pharma exec to patient advocate
-
Financial Times
The Covid-era tech that could reinvent cancer care
Previous
